Developments in Varicella Zoster Virus Vasculopathy
详细信息    查看全文
Baudouin E, Lantuejoul P. Les troublecas moteurs dans le zona. Gazette des Hopitaux. 1919. The first description of stroke associated with VZV.
2.•
Cheng-Ching E, Jones S, Hui FK, et al. High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy. J Neurol Sci. 2015;351:168–73. A study demonstrating decreased vessel wall thickening and decreased enhancement after antiviral treatment of VZV vasculopathy.CrossRef PubMed
3.Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging and virological features. Neurology. 2008;70:853–60.PubMedCentral CrossRef PubMed
4.Nagel MA, Forghani B, Mahalingam R, et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 2007;68:1069–73.CrossRef PubMed
5.Gilden D, Nagel MA, Cohrs RJ, Mahalingam R. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep. 2013;13:374.PubMedCentral CrossRef PubMed
6.Lin HC, Cw C, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792–7.CrossRef PubMed
7.Kang JH, Ho JD, Chen YH, et al. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40:3443–8.CrossRef PubMed
8.Sreenivasan N, Basit S, Wohlfahrt J, et al. The short- and long-term risk of stroke after herpes zoster—a nationwide population-based cohort study. PLoS One. 2013;8:e69156.PubMedCentral CrossRef PubMed
9.Breuer J, Pacou M, Gauthier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014;82:206–12.PubMedCentral CrossRef PubMed
10.Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis. 2014;58:1497–503.PubMedCentral CrossRef PubMed
11.Nagel MA, Traktinskiy I, Azarkh Y, et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology. 2011;77:364–70.PubMedCentral CrossRef PubMed
12.Nagel MA, Traktinskiy I, Stenmark KR, Frid MG, Choe A, Gilden D. Varicella zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology. 2013;80:62–8.PubMedCentral CrossRef PubMed
13.Gursoy G, Aktin E, Bahar S, et al. Post-herpetic aneurysm in the intrapetrosal portion of the internal carotid artery. Neuroradiology. 1980;9:279–82.
14.O’Donohue JM, Enzmann DR. Mycotic aneurysm in angiitis associated with herpes zoster ophthalmicus. AJNR Am J Neuroradiol. 1987;8:615–9.PubMed
15.Fukumoto S, Kinjo M, Hokamura K, et al. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster virus in the basilar artery lesions. Stroke. 1986;17:1024–8.CrossRef PubMed
16.Fulmer BB, Dillard SC, Musulman EM, et al. Two cases of cerebral aneurysms in HIV+ children. Pediatr Neurosurg. 1998;28:31–4.CrossRef PubMed
17.Saraya T, Shimura C, Wada H, et al. Evidence for vascular spread of varicella zoster-associated vasculopathy. Ann Intern Med. 2006;144:535–7.CrossRef PubMed
18.de Broucker T, Verollet D, Schoindre Y, et al. Cerebral vasculitis with aneurysms caused by varicella-zoster virus infection during AIDS: a new clinicoangiographical syndrome. Rev Neurol (Paris). 2008;164:61–71.CrossRef
19.Yasuda C, Okada K, Ohnari N, et al. Cerebral infarction and intracranial aneurysm related to the reactivation of varicella zoster virus in a Japanese acquired immunodeficiency syndrome (AIDS) patient. Rinsho Shinkeigaku. 2013;53:701–5.CrossRef PubMed
20.Bhayani N, Ranade P, Clark NM, et al. Varicella-zoster virus and cerebral aneurysm: case report and review of the literature. Clin Infect Dis. 2008;47:e1–3.CrossRef PubMed
21.Kawatani M, Nakai A, Okuno T, et al. A case of intracranial saccular aneurysm after primary varicella zoster virus infection. Brain Dev. 2012;34:80–2.CrossRef PubMed
22.•
Liberman AL, Nagel MA, Hurley MC, et al. Rapid development of nine cerebral aneurysms in varicella zoster virus vasculopathy. Neurology. 2014;82:2139–41. A study of aneurysms associated with VZV vasculopathy and improvement with antiviral therapy.PubMedCentral CrossRef PubMed
23.Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. JAMA. 2000;284:1271–9.CrossRef PubMed
24.Levin MJ, DeBiasi RL, Bostik V, et al. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis. 2008;198:1444–7.CrossRef PubMed
25.Iyer S, Mittal MK, Hodinka RL. Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child. Ann Emerg Med. 2009;53:792–5.CrossRef PubMed
26.Han JY, Hanson DC, Way SS. Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child. Pediatr Infect Dis J. 2011;30:266–8.CrossRef PubMed
27.Wirrell E, Hill MD, Jadavji T, et al. Stroke after varicella vaccination. J Pediatr. 2004;145:845–7.CrossRef PubMed
28.Sabry A, Hauk PJ, Jing H, et al. Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J Allergy Clin Immunol. 2014;133:1225–7.PubMedCentral CrossRef PubMed
29.Al-Abdulla NA, Rismondo V, Minkowski JS, et al. Herpes zoster vasculitis presenting as giant cell arteritis with bilateral internuclear ophthalmoplegia. Am J Ophthalmol. 2002;134:912–4.CrossRef PubMed
30.Al-Abdulla NA, Kelley JS, Green WR, et al. Herpes zoster vasculitis presenting as giant cell arteritis with choroidal infarction. Retina. 2003;23:567–9.CrossRef PubMed
31.de Castro LE, Peterson AM, Givre SJ, et al. Herpes zoster ophthalmicus: presenting as giant-cell arteritis. Clin Experiment Ophthalmol. 2005;33:636–8.CrossRef PubMed
32.••
Nagel MA, White T, Khmeleva N, et al. Analysis of varicella-zoster virus in temporal arteries biopsy-positive and -negative for giant cell arteritis. JAMA Neurol. 2015;72:1281–7. An extensive, retrospective study of temporal artery biopsies showing that most GCA-negative and GCA-positive arteries contain VZV antigen.
33.Salazar R, Russman AN, Nagel MA, et al. Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol. 2011;68:517–20.PubMedCentral CrossRef PubMed
34.Nagel MA, Khmeleva N, Boyer PJ, et al. Varicella zoster virus in the temporal artery of a patient with GCA. J Neurol Sci. 2013;335:229–30.CrossRef
35.Mathias M, Nagel MA, Khmeleva N, et al. VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci. 2013;325:180–2.PubMedCentral CrossRef PubMed
36.Nagel MA, Bennett JL, Khmeleva N, et al. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology. 2013;80:2017–21.PubMedCentral CrossRef PubMed
37.••Gilden D, White T, Khmeleva N, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2015;84:1948–55. The first extensive, retrospective study of temporal artery biopsies showing a causal link between VZV and biopsy-positive giant cell arteritis, as evidenced by the presence of VZV antigen, VZV DNA and herpesvirus particles in the temporal artery.CrossRef PubMed
38.Chakravarty EF, Michaud K, Katz R, et al. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus. 2013;22:238–44.CrossRef PubMed
39.Cavallasca JA, Costa CA, Mdel M, et al. Severe infections in patients with autoimmune diseases treated with cyclophosphamide. Reumatol Clin. 2015;11:221–3.CrossRef PubMed
40.Pappas DA, Hooper MM, Kremer JM, et al. Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease modifying anti-rheumatic drugs. Arthritis Care Res (Hoboken). 2015. doi:10.​1002/​acr.​22628 .
41.Tako J, Rado JP. Zoster meningoencephalitis in a steroid-treated patient. Arch Neurol. 1962;12:610–2.CrossRef
42.Nagel MA, Lenggenhager D, White T, et al. Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse. J Clin Virol. 2015;66:72–5.CrossRef PubMed
43.Galetta SL, Balcer LJ, Lieberman AP, et al. Refractory giant cell arteritis with spinal cord infarction. Neurology. 1997;49:1720–3.CrossRef PubMed
44.Gilden D, White T, Galetta SL, et al. Widespread arterial infection by varicella zoster virus explains refractory giant cell arteritis. Neurol Neuroimmunol Neuroinflamm. 2015;2:3125. doi:10.​1212/​NXI.​0000000000000012​5 .CrossRef
  • 作者单位：Maria A. Nagel (1)
    Don Gilden (1) (2)

    1. Department of Neurology, University of Colorado School of Medicine, 12700 E. 19th Avenue, Box B182, Aurora, CO, 80045, USA
    2. Department of Immunology & Microbiology, University of Colorado School of Medicine, 12700 E. 19th Avenue, Box B182, Aurora, CO, 80045, USA
  • 刊物主题：Neurology; Neurosciences;
  • 出版者：Springer US
  • ISSN：1534-6293
    • 文摘
    Varicella zoster virus (VZV) is a highly neurotropic human herpesvirus. Primary infection usually causes varicella (chicken pox), after which virus becomes latent in ganglionic neurons along the entire neuraxis. VZV reactivation results in zoster (shingles) which is frequently complicated by chronic pain (postherpetic neuralgia). VZV reactivation also causes meningoencephalitis, myelitis, ocular disorders, and vasculopathy, all of which can occur in the absence of rash. This review focuses on the association of VZV and stroke, and on the widening spectrum of disorders produced by VZV vasculopathy in immunocompetent and immunocompromised individuals, including recipients of varicella vaccine. Aside from ischemic stroke, VZV infection of cerebral arteries may lead to development of intracerebral aneurysms, with or without hemorrhage. Moreover, recent clinical-virological case reports and retrospective pathological-virological analyses of temporal arteries positive or negative for giant cell arteritis (GCA) indicate that extracranial VZV vasculopathy triggers the immunopathology of GCA. While many patients with GCA improve after corticosteroid treatment, prolonged corticosteroid use may potentiate VZV infection, leading to fatal vasculopathy in the brain and other organs.

    © 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

    地址：北京市海淀区学院路29号 邮编：100083

    电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700